STOCK TITAN

Kimberly-Clark (KMB) Stock News

KMB NASDAQ

Kimberly-Clark Corporation manufactures branded personal care, consumer tissue and professional hygiene products sold in more than 175 countries and territories. Its portfolio includes Huggies, Pull-Ups, Goodnites, Kotex, Depend, Poise, Kleenex, Scott, Cottonelle and WypAll, with updates often tied to product launches, brand initiatives, retailer availability and consumer-use innovations.

Recurring company developments include quarterly operating results, volume and pricing trends, productivity actions, investor conference presentations, governance and ethics matters, and supply-chain or logistics events affecting customer service. The company’s disclosures also describe its North American and international market activity and the role of major tissue and hygiene brands in its sales mix.

Rhea-AI Summary

Kimberly-Clark (Nasdaq: KMB) reported third-quarter net sales of $4.1 billion and reaffirmed its 2026 standalone outlook after completing the Kenvue transaction. Sales fell 0.4%, while organic sales, excluding currency and business exits, declined 1.3%. Adjusted operating profit fell 0.9% to $677 million. Adjusted earnings per share from continuing operations rose 17.2% to $1.70, helped by lower interest expense and taxes.

North America sales rose 0.9%, while International Personal Care sales fell 2.8%, with China social media disruption weighing on results. First-nine-month operating cash flow, including discontinued operations, reached $2.4 billion versus $1.8 billion. Debt from continuing operations fell to $6.5 billion from $7.2 billion at year-end. The company expects mid-single-digit adjusted operating profit growth and high-single-digit adjusted continuing-operations EPS growth, both on a constant-currency basis.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.54%
Tags
-
Rhea-AI Summary

Kimberly-Clark (NASDAQ: KMB) announced final tender results for offers to exchange Kenvue notes for up to $7 billion in new notes. The offers expired on November 2, 2026, with settlement expected on November 4, 2026. Participation ranged from 73.93% of the 2028 notes to 98.54% of the 2053 notes across seven series.

For each $1,000 tendered and accepted, eligible holders receive $970 in Kimberly-Clark notes plus a $30 premium in notes. Holders tendering by October 9 also qualify for $1 in cash per $1,000. The new unsecured senior obligations retain the corresponding Kenvue notes’ interest rates, interest payment dates, maturities and optional redemption prices. Required consents were obtained and a supplemental agreement governing the debt was executed; its amendments become operative only upon settlement. The first new-note interest payment includes unpaid interest accrued on the exchanged notes.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.50%
Tags
none
-
Rhea-AI Summary

Kimberly-Clark (KMB) completed its acquisition of Kenvue, combining personal care and consumer health portfolios that include 10 billion-dollar brands. Kenvue shareholders will receive $3.50 in cash and 0.14625 Kimberly-Clark shares for each share held. Kenvue (KVUE) ceased trading on the New York Stock Exchange at the market opening on November 2, 2026.

Kimberly-Clark reaffirmed anticipated run-rate synergies of approximately $2.1 billion: approximately $1.9 billion in cost synergies captured in the first three years after closing, plus approximately $500 million in incremental profit from revenue synergies, partially offset by approximately $300 million of reinvestment, captured within four years. It will operate through North America, Asia Pacific Focus Markets, EMEA and Enterprise Markets. Three former Kenvue directors joined Kimberly-Clark's board, which now has 13 directors; three Kimberly-Clark directors stepped down.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.29%
Tags
Rhea-AI Summary

S&P Dow Jones Indices, a division of S&P Global (SPGI), will change three indexes before trading opens November 4, 2026.

Okta (OKTA) will replace Kenvue (KVUE) in the S&P 500. Glaukos (GKOS) will replace Okta in the S&P MidCap 400, while McGrath RentCorp (MGRC) will replace Glaukos in the S&P SmallCap 600. Loar Holdings (LOAR) will also join the S&P SmallCap 600, replacing LiveRamp Holdings (RAMP).

Kimberly-Clark (KMB), an S&P 500 constituent, is acquiring Kenvue. Publicis Groupe is acquiring LiveRamp. Both deals are expected to close soon, pending final closing conditions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.29%
Tags
none
-
Rhea-AI Summary

Kimberly-Clark (NASDAQ: KMB) has completed a private offering of $4.9 billion in senior unsecured notes to help finance its proposed Kenvue acquisition.

The five tranches comprise $750 million at 5.100% due 2028, $1 billion at 5.300% due 2029, $1.25 billion at 5.450% due 2031, $750 million at 5.650% due 2034 and $1.15 billion at 5.800% due 2036.

Kimberly-Clark intends to combine net proceeds with cash on hand and/or commercial paper borrowings to fund the acquisition's cash consideration and related fees and expenses. Any remaining net proceeds are expected to support general corporate purposes. The acquisition remains proposed and subject to customary closing conditions. The company expects earnings growth from synergies, free cash flow and scheduled debt maturities to support accelerated debt reduction to levels consistent with its current credit ratings.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.89%
Tags
private placement debt offering offering
-
Rhea-AI Summary

Kimberly-Clark (NASDAQ: KMB) extended its Kenvue note exchange offers to November 2, 2026, with all other terms unchanged. The deadline moves from October 27 to 5:00 p.m., New York City time, on November 2. The offers cover any and all outstanding notes across seven Kenvue series in exchange for up to $7 billion in new Kimberly-Clark notes.

As of October 27, tendered principal ranged from 73.93% to 98.54% of each series outstanding. Completion depends on Kimberly-Clark's pending acquisition of Kenvue, a condition it cannot waive. Kimberly-Clark expects settlement promptly after expiration. Required consents for indenture amendments were received October 9; those amendments become operative only upon settlement. The offering memorandum also incorporates Kenvue's unaudited financial statements for the three and nine months ended September 27, 2026, and September 28, 2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.64%
Tags
none
Rhea-AI Summary

Kimberly-Clark (NASDAQ: KMB) priced a $4.9 billion private offering of senior unsecured notes to help finance its proposed acquisition of Kenvue.

The five tranches comprise $750 million at 5.100% due 2028, $1 billion at 5.300% due 2029, $1.25 billion at 5.450% due 2031, $750 million at 5.650% due 2034 and $1.15 billion at 5.800% due 2036. Kimberly-Clark expects the offering to close October 29, 2026, and the acquisition in the fourth quarter of 2026, subject to customary closing conditions. Net proceeds, alongside cash on hand and/or commercial paper borrowings, are intended to fund acquisition cash consideration and related fees and expenses. The offering does not depend on the acquisition closing, but specified acquisition-related triggers require redemption at 101% of principal plus accrued and unpaid interest. Kenvue would guarantee the notes under specified conditions involving separate exchange offers.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.77%
Tags
private placement debt offering offering
-
Rhea-AI Summary

Kimberly-Clark (KMB) has launched Big Dreams diapers and wipes exclusively in Amazon's U.S. stores for parents and caregivers. Developed in collaboration with Amazon, the collection is available in a selection of sizes, pack quantities and formats, with prices starting at $8.99 for diapers and $7.99 for wipes.

The products can be delivered directly to customers' homes. Eligible products are also available through Amazon Registry and Subscribe & Save. The diapers are fragrance-free, and the wipes are made with 99% water.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.15%
Tags
none
-
Rhea-AI Summary

Kimberly-Clark (KMB) provided preliminary third-quarter financial data and maintained its full-year outlook, with final results due November 5, 2026.

The company expects 2026 organic sales growth approximately 100 basis points below weighted average category growth, now approximately 1.7% on a trailing 12-month basis. Previously disclosed China social media disruptions account for approximately 100 basis points of realized and potential unfavorable impacts at the total-company level. On a constant-currency basis, its outlook calls for mid-single-digit adjusted operating profit growth, high-single-digit growth in adjusted earnings per share from continuing operations, and a low-single-digit decline in adjusted earnings per share attributable to Kimberly-Clark. The preliminary data cover the three months ended September 30, 2026.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.69%
Tags
Rhea-AI Summary

Kimberly-Clark (KMB) secured the required consents to amend all outstanding Kenvue notes and expanded the consideration available to late tendering holders.

The exchange offers cover up to $7 billion in new Kimberly-Clark notes plus cash. Kenvue executed a supplemental indenture, but its amendments become operative only upon settlement. Early participation ranged from 73.64% to 98.37% across seven series. Accepted tenders receive $970 in new notes plus a $30 note premium per $1,000 tendered; qualifying early holders also receive $1 cash.

The offers currently expire October 27, 2026, at 5:00 p.m. New York City time. Kimberly-Clark expects to extend expiration to around the acquisition closing, expected in the fourth quarter of 2026. Settlement is not anticipated before November 2, 2026. The exchanges depend on completion of the acquisition, a condition Kimberly-Clark cannot waive.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.49%
Tags
none

FAQ

What is the current stock price of Kimberly-Clark (KMB)?

Kimberly-Clark (KMB) last closed at $111.93.

What is the market cap of Kimberly-Clark (KMB)?

The market cap of Kimberly-Clark (KMB) is approximately $68.7B.